All SEC Filings :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

All SEC Filings

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
08/21/15	DEF 14A	Definitive proxy statements			27
08/18/15	8-K	Current report filing Documents EX-99.1			5
08/14/15	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			31
08/03/15	S-1/A	General form of registration statement for all companies including face-amount certificate companies Documents EX-5.1 EX-10.11 EX-10.12 EX-10.13 EX-21.1 EX-23.1			104
08/03/15	DEL AM	Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement			1
08/03/15	AW	Withdrawal of amendment to a registration statement filed under the Securities Act			1
07/30/15	S-1/A	General form of registration statement for all companies including face-amount certificate companies Documents EX-5.1 EX-10.11 EX-10.12 EX-10.13 EX-21.1 EX-23.1			104
07/20/15	S-1	General form of registration statement for all companies including face-amount certificate companies Documents EX-5.1 EX-21.1 EX-23.1			94
07/20/15	8-K	Current report filing Documents EX-10.1 EX-10.2			54
07/09/15	4	Statement of changes in beneficial ownership of securities			1

24
25
26
27
28
29
30
31
32
33